19-nor-steroid derivatives with a 15alpha,16alpha-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives

Details for Australian Patent Application No. 2008342916 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Menges, Frederik; Bohlmann, Rolf; Borden, Steffen; Muhn, Hans-Peter; Kuhnke, Joachim; Klar, Ulrich; Frenzel, Thomas; Prelle, Katja; Hubner, Jan; Ring, Sven

Agent Davies Collison Cave

Pub. Number AU-A-2008342916

PCT Pub. Number WO2009/083272

Priority 10 2007 063 495.3 29.12.07 DE

Filing date 23 December 2008

Wipo publication date 9 July 2009

International Classifications

A61K 31/585 (2006.01)

A61P 5/34 (2006.01) Drugs for disorders of the endocrine system

C07J 53/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms

Event Publications

15 July 2010 PCT application entered the National Phase

  PCT publication WO2009/083272 Priority application(s): WO2009/083272

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008342918-Measuring and reading the size of a parameter of a remotely positioned device

2008342915-15,16-methylene-17-(1'-propenyl)-17,3'- oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative